Status:
RECRUITING
PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics
Lead Sponsor:
Tomsk National Research Medical Center of the Russian Academy of Sciences
Conditions:
Potentially Inappropriate Medications
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to assess the incidence of potentially inappropriate medication (PIM) administration, polypharmacy, and potential drug-drug-interactions (PDDIs) in cardiovascular patients enro...
Detailed Description
Objective: It is essential to improve patient safety by determining an individual's exposure to potentially inappropriate drugs. This study will be performed to find out the incidence of potentially ...
Eligibility Criteria
Inclusion
- established diagnosis of cardiovascular disease
- age of 18 years and older
- enrollment in the reimbursement program in Tomsk Region
Exclusion
- age of 17 years and younger
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05336565
Start Date
July 1 2022
End Date
December 31 2027
Last Update
December 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tomsk NRMC
Tomsk, Russia, 634012